A new verification link is sent. Check email. Resend confirmation email
ACTEMRA 400mg/20ml
$1,099.00
| Quantity | Discount (%) | Price |
|---|---|---|
| 1 - 5 | — | $1,099.00 |
| 6 - 10 | 10.01 % | $989.00 |
| 11 - 20 | 10.92 % | $979.00 |
| 21+ | 11.83 % | $969.00 |
Actemra 400mg Injection contains tocilizumab, an interleukin-6 (IL-6) receptor antagonist monoclonal antibody used for the treatment and management of various inflammatory and autoimmune diseases. It works by blocking the IL-6 receptor, a key mediator of inflammation, thereby reducing pain, swelling, and other symptoms associated with conditions such as rheumatoid arthritis, juvenile idiopathic arthritis, giant cell arteritis, and other immune disorders. This medicine is administered by healthcare professionals as an intravenous infusion and is commonly used when other therapies have not produced adequate response. Treatment is individualized by the specialist based on disease severity, patient weight, and clinical response, with regular monitoring recommended throughout the course of therapy.



